IMPACT OF ONCE-WEEKLY SUBCUTANEOUS SEMAGLUTIDE 2.4 MG ON METABOLIC SYNDROME IN THE 2-YEAR, RANDOMIZED CONTROLLED STEP 5 TRIAL
| Autor: | Azar, M., Batterham, R., Bhatta, M., Holst-Hansen, T., Kandler, K., Rigas, G., Garvey, T. |
|---|---|
| Zdroj: | In Canadian Journal of Diabetes November 2023 47(7) Supplement:S131-S131 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect